KPP
TMO icon

Kings Path Partners’s Thermo Fisher Scientific TMO Stock Holding History

Kings Path Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,637
Closed -$1.37M – 290
2024
Q4 		$1.37M Buy
2,637
+306
+13% +$168K 0.59% 36
2024
Q3 		$1.44M Hold
2,331
– – 0.61% 35
2024
Q2 		$1.29M Buy
+2,331
New +$1.34M 0.61% 40

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Kings Path Partners's TMO Position: Q1 2025 in Review

Kings Path Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 2,637 shares — an estimated $1.37M sold.

Kings Path Partners first reported a position in TMO in Q2 2024 and held it in 3 quarters. The position peaked at $1.44M in Q3 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Kings Path Partners reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Kings Path Partners sold 2,637 Thermo Fisher Scientific shares in Q1 2025, an estimated $1.37M.
  • Kings Path Partners first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 3 quarters.
  • Kings Path Partners's Thermo Fisher Scientific position peaked at $1.44M in Q3 2024.
  • 2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Kings Path Partners's 13F filing for Q1 2025, filed 4 Apr 2025.